{{Rsnum
|rsid=12051272
|Gene=CDH13
|Chromosome=16
|position=82629683
|Orientation=plus
|GMAF=0.09917
|Gene_s=CDH13
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 98.3 | 1.7 | 0.0
| HCB | 62.5 | 30.0 | 7.5
| JPT | 57.1 | 35.7 | 7.1
| YRI | 98.2 | 1.8 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 62.5 | 30.0 | 7.5
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22065538
|Trait=None
|Title=CDH13 gene coding T-cadherin influences variations in plasma adiponectin levels in the Japanese population.
|RiskAllele=
|Pval=5E-40
|OR=None
|ORtxt=None
}}
{{PMID Auto GWAS
|PMID=22479202
|Trait=None
|Title=Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals.
|RiskAllele=T
|Pval=1E-14
|OR=0.2600
|ORtxt=None
|OA=1
}}